Media Thread, page-8118

This interview with Paul Hooper is a couple of years old and so many LT holders would have seen it, but for those that want to gain some insight into Paul Hoopers views and the roll he sees that small Biotech play in the BP industry, this is very much worth watching. Not withstanding that I do not think a buyout in Phase II is what will happen there is a bigger prize i feel.

What is helpful is that what Paul says is understandable to everyone you do not have to have a Phd and it relates more about the commercial path and possible success that IMU are on rather than the intricate science behind IMU

I think that given the results to date, where we are with trials, and the very smart people involved, the inflection points that we are all hoping for including those that suffer from cancer may not be far away.

Worth a watch I'd say

DYOR